A new Centers for Disease Control and Prevention (CDC) study reports that deaths stemming from the hepatitis C virus infection (HCV) continue to rise in the United States. Even though Hepatitis C medications now exist that cure the disease in 90 percent of patients who take it, insurers are placing overly restrictive cost-containment barriers on the treatments, thereby preventing patients from accessing them. You can read more on this topic on Aids Map’s website.
Last Updated on May 7, 2020 by Aimed Alliance
